Stalk us here
Powered by Fresh Ideas

Novonesis Plans to Build €600 Million Enzyme Facility in India by 2030

India 07.09.2026
Source: www.foodbev.com
EN 中文 DE FR عربى
Novonesis has announced a significant investment to expand its Patalganga, India facility with a new enzyme production plant valued at €600 million. The facility aims to increase production capacity to meet global demand and is expected to be operational by 2030.
Novonesis Plans to Build €600 Million Enzyme Facility in India by 2030

Novonesis, a company formed from the merger of Novozymes and Chr. Hansen, has revealed its plans to construct a €600 million enzyme production facility in Patalganga, India. This development is a key part of the company's strategy to expand its production capabilities to meet increasing global demand for bio-solutions. Scheduled for completion by 2030, the plant is expected to enhance Novonesis' international supply network.

The new facility will focus on producing enzymes for various sectors, including the food and beverage industry, biofuels, and household care. This initiative is set to bring Novonesis closer to its customers in markets across the Middle East, India, and Africa, which are projected to grow more rapidly than developed markets in the coming years.

Patalganga is part of a broader investment strategy by Novonesis, which also includes the enhancement of facilities in Rayong, Thailand; Franklinton, North Carolina; Taicang, China; Araucaria, Brazil; and West Allis, Wisconsin. Their efforts focus on bolstering global production setups to serve customers more effectively.

Environmental considerations are a significant aspect of the project, with freshwater recycling initiatives planned to reduce water usage and integrated heat pumps intended to lower energy consumption. These measures aim to decrease the facility's Scope 1 and 2 emissions, aligning with the company's sustainability goals.

According to Anders Lund, Chief Operating Officer at Novonesis, expanding the company's global production capacity is crucial as the demand for biosolutions continues to grow. The Patalganga project is expected to improve the company's operational resilience, efficiency, and supply flexibility.

Novonesis employs 11,000 people globally and specializes in microbial science, fermentation, and enzyme innovation. The company views the new facility as a milestone in its growth strategy, contributing to meeting long-term growth targets.